Carlton M. Johnson has served as a director of Peregrine since 1999. Mr. Johnson currently serves as legal counsel for Roswell Capital Partners, LLC and has served as legal counsel for Equiplace Securities, LLC (formerly Swartz Investments, LLC) since 1996. Mr. Johnson is an active member of the Alabama State Bar, the Florida Bar and the State Bar of Georgia. He has been a member of the Florida law firm of Smith, Sauer, DeMaria & Johnson and Vice President and President-Elect of the 600 member Escambia-Santa Rosa Bar Association. Mr. Johnson earned his degree with high honors in History/Political Science at Auburn University and his JD degree, also with high honors, at Samford University - Cumberland School of Law. Mr. Johnson also serves on the board of Patriot Scientific Corporation, a publicly traded company.

Steven King has been President and Chief Executive Officer of Peregrine since March 2003. Mr. King started with Peregrine in 1997 as the Director of Research and Development. He first was promoted to Senior Director of Research and Development and then to Vice President of Technology and Product Development. In 2000, Mr. King was also given the responsibility of bringing the company's biologics manufacturing facility into full cGMP compliance and then launching its wholly owned contract manufacturing subsidiary, Avid Bioservices. Since 2001, Mr. King has served as the President and CEO of Avid Bioservices, and was promoted to Peregrine's Chief Operating Officer at that time. Prior to joining Peregrine, Mr. King was employed at a corporation that was developing Vascular Targeting Agents (VTA), which was acquired by Peregrine in 1997. Mr. King previously worked with Dr. Philip Thorpe, inventor of the VTA technology, at the University of Texas Southwestern Medical Center at Dallas and is a co-inventor on over 25 U.S. and foreign patents and patent applications in the VTA area. Mr. King holds BS and MS degrees in Biology from Texas Tech University.

Mr. Pohl served as Chairman of the Board, President and CEO of Patriot Scientific Corporation from June 2005 to June 2007, and was a member of its board of directors from April 2001 until February 2008. Mr. Pohl also served as an officer of Patriot from January 2001 to March 2002. He is currently Chairman of the Board of Wellness.com, Inc., a privately held Internet enterprise, and two of its affiliates. Mr. Pohl was in the private practice of law counseling business clients from 1997 to 2005, and from 1995 to 1996 was Special Counsel to the Ohio Attorney General regarding entrepreneurial investments by state employee pension funds. Previously, he was a Senior Attorney with Jones Day Reavis & Pogue, a large U.S. law firm, and held positions as a senior officer and general counsel in large financial services corporations that developed assets of more than $1 billion. Mr. Pohl is a member of the Corporate Directors Forum of San Diego, the Intellectual Property Law and Business Law Sections of the State Bar of California, has served as a member of the Board of Governors of the Corporate Counsel Section of the Ohio State Bar Association, and is an Emeritus member of the Board of Directors of the American Financial Services Association, Washington, D.C. Mr. Pohl earned a Juris Doctor degree from the Ohio State University College of Law, and also holds a B.S. in Administrative Sciences from Ohio State.

Eric S. Swartz has served as a director of Peregrine since 1999. Mr. Swartz is the founder and President of Roswell Capital Partners, LLC and previous founder and President of Equiplace Securities, LLC (formerly Swartz Investments, LLC), which he started in 1993. Prior to 1993, Mr. Swartz was a Vice President at Bear Stearns & Co. specializing in foreign institutional equity investments in U.S. securities. Prior to that, Mr. Swartz was a Vice President with Oppenheimer & Co., where he was involved in overseas placements of equity and debt for institutions in Germany, Austria, Switzerland, France, Australia, and New Zealand. Mr. Swartz has approximately 20 years of experience in the securities business.